FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Buspirone HCl Tablets
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Impax Laboratories (New 08/25/2017)

Company Contact Information:
877-994-6729

Presentation Posting Date Related Information
5 mg tablets; 100 tablets/bottle (NDC 0115-1690-01) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
5 mg tablets; 500 tablets/bottle (NDC 0115-1690-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
5 mg tablets; 1000 tablets/bottle (NDC 0115-1690-03) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
10 mg tablets; 100 tablets/bottle (NDC 0115-1691-01) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
10 mg tablets; 500 tablets/bottle (NDC 0115-1691-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
10 mg tablets; 1000 tablets/bottle (NDC 0115-1691-03) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
15 mg tablets; 500 tablets/bottle (NDC 0115-1692-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
15 mg tablets; 60 tablets/bottle (NDC 0115-1692-13) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.
15 mg tablets; 180 tablets/bottle (NDC 0115-1692-19) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is February 2018.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English